Literature DB >> 28925574

Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.

Reoto Takei1, Machiko Arita1, Shogo Kumagai1, Yuhei Ito1, Fumiaki Tokioka1, Takashi Koyama2, Rintaro Saito3, Keisuke Nishimura3, Hironobu Tokumasu4, Tadashi Ishida1.   

Abstract

BACKGROUND AND
OBJECTIVE: Interstitial lung disease (ILD) is a common pulmonary manifestation of systemic sclerosis (SSc). It is unknown whether radiographic fibrosis score predicts mortality in SSc-associated ILD (SSc-ILD). We retrospectively analysed patients with SSc-ILD to evaluate whether radiographic fibrosis score was a useful predictor of mortality.
METHODS: We identified SSc-ILD patients evaluated at Kurashiki Central Hospital (Japan) from 2006 to 2016, and radiographic fibrosis scores based on the extent of reticulation and honeycombing on high-resolution computed tomography (HRCT) scanning were calculated by manually tracing around each fibrotic area. Independent predictors of overall survival were determined using the Cox proportional hazards model.
RESULTS: The study included 48 patients, of whom 19 had usual interstitial pneumonia on HRCT. The median follow-up period was 56.6 months, and over the follow-up period 15 patients died. The 5-year survival was 72.4%. In the multivariate analysis, radiographic fibrosis score, age, being male and forced vital capacity were independently associated with an increased risk of death, while HRCT pattern was not.
CONCLUSION: A high radiographic fibrosis score was a poor prognostic factor in SSc-ILD. More widespread fibrosis was associated with an increased risk of death, independent of HRCT pattern.
© 2017 Asian Pacific Society of Respirology.

Entities:  

Keywords:  Japanese; high-resolution computed tomography; interstitial lung disease; radiographic pulmonary fibrosis; systemic sclerosis

Mesh:

Year:  2017        PMID: 28925574     DOI: 10.1111/resp.13175

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  11 in total

1.  The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Authors:  Thi Dan Linh Nguyen-Kim; Britta Maurer; Yossra A Suliman; Fabian Morsbach; Oliver Distler; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review.

Authors:  Anna-Maria Hoffmann-Vold; Toby M Maher; Edward E Philpot; Ali Ashrafzadeh; Oliver Distler
Journal:  ERJ Open Res       Date:  2021-02-22

Review 3.  Management of systemic sclerosis-associated interstitial lung disease.

Authors:  David Roofeh; Sara Jaafar; Dharshan Vummidi; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

4.  [Modern drug therapy for systemic sclerosis associated interstitial lung disease].

Authors:  Martin Aringer; Dirk Koschel; Andreas Krause; Udo Schneider; Sven Gläser
Journal:  Dtsch Med Wochenschr       Date:  2021-12-03       Impact factor: 0.628

5.  Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis-Interstitial Lung Disease: A Systematic Review.

Authors:  Nicholas Landini; Martina Orlandi; Cosimo Bruni; Edoardo Carlesi; Cosimo Nardi; Linda Calistri; Giovanni Morana; Sara Tomassetti; Stefano Colagrande; Marco Matucci-Cerinic
Journal:  Front Med (Lausanne)       Date:  2022-01-27

Review 6.  Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis.

Authors:  Surabhi Agarwal Khanna; John W Nance; Sally A Suliman
Journal:  Curr Rheumatol Rep       Date:  2022-05-01       Impact factor: 4.686

7.  Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.

Authors:  Minna Mononen; Eeva Saari; Hannele Hasala; Hannu-Pekka Kettunen; Sanna Suoranta; Hanna Nurmi; Miia Kärkkäinen; Tuomas Selander; Jukka Randell; Jari Laurikka; Toomas Uibu; Heikki Koskela; Riitta Kaarteenaho; Minna Purokivi
Journal:  BMC Pulm Med       Date:  2022-08-14       Impact factor: 3.320

8.  Update on Morbidity and Mortality in Systemic Sclerosis-Related Interstitial Lung Disease.

Authors:  Elizabeth R Volkmann; Aryeh Fischer
Journal:  J Scleroderma Relat Disord       Date:  2020-05-22

Review 9.  Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.

Authors:  Dinesh Khanna; Alain Lescoat; David Roofeh; Elana J Bernstein; Ella A Kazerooni; Michael D Roth; Fernando Martinez; Kevin R Flaherty; Christopher P Denton
Journal:  Arthritis Rheumatol       Date:  2021-11-10       Impact factor: 15.483

10.  Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases.

Authors:  Andreina Manfredi; Giulia Cassone; Caterina Vacchi; Fabrizio Pancaldi; Giovanni Della Casa; Stefania Cerri; Lisa De Pasquale; Fabrizio Luppi; Carlo Salvarani; Marco Sebastiani
Journal:  Arch Rheumatol       Date:  2020-06-25       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.